Utrecht, Netherlands

Genmab Holding B.v.


USPTO Granted Patents = 6


Trademarks = 1

Forward Citations = 16

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Simone Oostindie (6 out of 9 patents)

silverMedal Esther Breij (6 out of 14 patents)

bronzeMedal Paul Parren (6 out of 136 patents)

4.  Hilma Van Der Horst (6 out of 6 patents)

5.  Tuna Mutis (6 out of 6 patents)

6.  Margaret A Lindorfer (6 out of 11 patents)

7.  Frank Beurskens (5 out of 15 patents)

8.  Marije Overdijk (5 out of 10 patents)

9.  Martine E D Chamuleau (5 out of 5 patents)

10.  Andreas Hollenstein (4 out of 4 patents)

11.  Ronald P Taylor (4 out of 15 patents)

12.  Edward Norbert Van Den Brink (4 out of 57 patents)

13.  Martine Ed Chamuleau (1 out of 1 patent)

14.  Frank Beurskens (1 out of 1 patent)

15.  Edward Van Den Brink (1 out of 2 patents)


6 patents:

Company Overview
Genmab is an international biotechnology company specializing in the creation and development of innovative antibody-based therapies for the treatment of cancer and other diseases. Their products are based on their cutting-edge antibody technology platforms, including DuoBody, HexaBody, and UniBody. Genmab collaborates with leading pharmaceutical and biotechnology companies to bring their therapies to market, ultimately improving patient outcomes and quality of life.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#23 in Utrecht

#971 in Netherlands

Utrecht, NL
Utrecht, Netherlands
Forward Citations = 16

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genmab Holding B.v.. Retrieved from https://idiyas.com/company/genmab-holding-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…